A new study finds that is particularly true for people nearing retirement.

A new study finds that when stock prices fall, antidepressant prescriptions rise, especially for people who are closer to ...

The FDA recently announced a recall of over 7,000 bottles of duloxetine after detecting elevated levels of ...

Production of Prozac, an antidepressant, would end globally at the end of this year, drugmaker Eli Lilly and Co said in a press release yesterday after announcing in August that the drug would soon be ...

The FDA is recalling more than 7,000 bottles of the antidepressant duloxetine due to a possible cancer-causing chemical.

They suggest other fast-acting antidepressants could offer a competitive challenge to J&J's drug, including Axsome Therapeutics' recently approved Auvelity (bupropion/dextromethorphan), Sage ...

Global Stuttering Therapeutics MarketThe global stuttering therapeutics market, valued at USD 43 million in 2023, is on track ...

Bupropion hydrochloride extended-release tablets are widely prescribed for the treatment of major depressive disorder and for ...

The market for antidepressants is, however, getting more competitive after years of stagnation, with a string of new drugs on or approaching the market including AbbVie’s Vraylar (cariprazine ...